UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000001990 |
|---|---|
| Receipt number | R000002421 |
| Scientific Title | Randomized phase II study comparing Gemcitabine/TS-1 combination chemoradiotherapy with Gemcitabine/TS-1 combination chemotherapy for unresectable locally advanced pancreatic cancer. |
| Date of disclosure of the study information | 2009/05/22 |
| Last modified on | 2017/05/16 19:11:46 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2009/05/21 10:01:13 | ||
| 2 | Update | 2009/11/21 19:19:01 | Recruitment status |
|
| 3 | Update | 2009/11/21 19:20:27 | Institutions |
|
| 4 | Update | 2009/11/21 19:21:07 | Institutions |
|
| 5 | Update | 2011/07/02 09:35:50 | Name of person sending information Organization Division name Address Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 6 | Update | 2012/12/04 15:03:36 | Last follow-up date |
|
| 7 | Update | 2012/12/04 15:07:31 | Secondary IDs Study ID_1 Org. issuing International ID_1 Org. issuing International ID_1 Institutions |
|
| 8 | Update | 2012/12/04 15:07:58 | Institutions |
|
| 9 | Update | 2013/01/15 09:36:39 | Recruitment status Last follow-up date |
|
| 10 | Update | 2013/11/21 09:02:39 | Email |
|
| 11 | Update | 2014/06/08 12:23:57 | Last follow-up date Date of closure to data entry Date trial data considered complete |
|
| 12 | Update | 2014/11/21 09:06:00 | Publication of results |
|
| 13 | Update | 2015/05/21 18:45:38 | Recruitment status Date analysis concluded |
|
| 14 | Update | 2017/05/16 19:11:13 | Name of primary person or sponsor Organization |
|
| 15 | Update | 2017/05/16 19:11:46 | Date of protocol fixation |
